Ferritin‐based drug delivery system for tumor therapy
BMEMat · 2023-06 · 1 (2)
DOI: 10.1002/bmm2.12022 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMEMat, online erschienen am 26.04.2023. Verfasst von Zaiqian Tu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ferritin has been widely used in drug delivery in recent years due to its unique spherical nanocage structure. In addition, the natural targeting and good biocompatibility of ferritin make it an excellent drug delivery system. Therefore, ferritin has shown a broad application prospect in the field of nanomedicine. In this perspective, we will describe ferritin‐based drug delivery system, ferritin‐based drug delivery system for tumor treatment, and future challenges in ferritin development. Hopefully, this perspective may inspire the future development of ferritin‐based drug delivery systems for tumor treatment.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
- National Natural Science Foundation of China
Zitieren
APA
Tu, Z., Timashev, P., Chen, J., & Liang, X. (2023). Ferritin‐based drug delivery system for tumor therapy. BMEMat, 1(2). https://doi.org/10.1002/bmm2.12022
Vancouver
Tu Z, Timashev P, Chen J, Liang X. Ferritin‐based drug delivery system for tumor therapy. BMEMat. 2023;1(2). doi:10.1002/bmm2.12022
BibTeX
@article{Tu2023,
author = {Tu, Zaiqian and Timashev, Peter and Chen, Junge and Liang, Xing‐Jie},
title = {Ferritin‐based drug delivery system for tumor therapy},
journal = {BMEMat},
year = {2023},
volume = {1},
number = {2},
doi = {10.1002/bmm2.12022}
}
EUVIMED